<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta name="description" content="Guide to polymyositis - inflammatory muscle disease causing progressive weakness in proximal muscles.">
    <meta name="keywords" content="polymyositis, inflammatory myopathy, muscle inflammation, autoimmune muscle disease, muscle weakness">
    <title>Polymyositis | ChronicSoreness</title>
    <link rel="stylesheet" href="../css/styles.css">
</head>
<body>
    <header class="header"><nav class="nav-container"><div class="logo"><a href="../index.html"><span class="logo-icon">ðŸ’œ</span><span class="logo-text"><strong>Chronic</strong>Soreness</span></a></div><button class="mobile-menu-toggle" aria-label="Toggle menu"><span class="hamburger"></span></button><ul class="nav-menu"><li><a href="../conditions.html">Conditions</a></li><li><a href="../treatments.html">Treatments</a></li><li><a href="../medications.html">Medications</a></li><li><a href="../exercise.html">Exercise</a></li><li><a href="../nutrition.html">Nutrition</a></li><li><a href="../mental-health.html">Mental Health</a></li></ul></nav></header>
    <main id="main-content">
        <article class="page-header"><h1>Polymyositis</h1><p>Inflammatory disease of muscles</p></article>
        <section class="content-section">
            <div class="container">
                <h2>What Is Polymyositis?</h2>
                <p>Polymyositis is an inflammatory myopathy causing chronic muscle inflammation and weakness. It primarily affects proximal muscles (shoulders, hips, thighs). It's part of a group of conditions called inflammatory myopathies.<sup>1</sup></p>

                <h2>Related Conditions</h2>
                <ul>
                    <li><strong>Dermatomyositis</strong> - With skin involvement</li>
                    <li><strong>Inclusion body myositis</strong> - Different pattern, older adults</li>
                </ul>

                <h2>Symptoms<sup>2</sup></h2>
                <ul>
                    <li>Progressive muscle weakness</li>
                    <li>Difficulty rising from chairs</li>
                    <li>Trouble climbing stairs</li>
                    <li>Difficulty lifting arms overhead</li>
                    <li>Muscle pain and tenderness</li>
                    <li>Fatigue</li>
                    <li>Swallowing difficulty (some cases)</li>
                </ul>

                <h2>Diagnosis</h2>
                <ul>
                    <li>Elevated muscle enzymes (CK, aldolase)</li>
                    <li>EMG abnormalities</li>
                    <li>Muscle biopsy</li>
                    <li>MRI showing inflammation</li>
                    <li>Autoantibodies</li>
                </ul>

                <h2>Treatment<sup>3</sup></h2>
                <h3>Medications</h3>
                <ul>
                    <li>Corticosteroids (first-line)</li>
                    <li>Methotrexate</li>
                    <li>Azathioprine</li>
                    <li>IVIG</li>
                    <li>Rituximab (refractory cases)</li>
                </ul>

                <h3>Rehabilitation</h3>
                <ul>
                    <li>Physical therapy essential</li>
                    <li>Maintain range of motion</li>
                    <li>Strengthen when inflammation controlled</li>
                </ul>

                <h2>Prognosis</h2>
                <p>Most respond to treatment, though it may take months. Some have chronic symptoms requiring long-term immunosuppression.</p>

                <h2>References</h2>
                <ol>
                    <li>Dalakas MC. Inflammatory muscle diseases. <em>N Engl J Med</em>. 2015;372(18):1734-1747.</li>
                    <li>Lundberg IE, TjÃ¤rnlund A, Bottai M, et al. 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies. <em>Arthritis Rheumatol</em>. 2017;69(12):2271-2282.</li>
                    <li>Oddis CV, Reed AM, Aggarwal R, et al. Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis. <em>Arthritis Rheum</em>. 2013;65(2):314-324.</li>
                </ol>
            </div>
        </section>
    </main>
    <footer class="footer"><div class="container"><p class="disclaimer">The information provided is for educational purposes only and is not medical advice.</p><p class="copyright">Â© 2024 ChronicSoreness. All rights reserved.</p></div></footer>
    <script src="../js/main.js"></script>
</body>
</html>
